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Hypokalemia 
Background 
1. Definition:  
o Serum potassium < 3.5 mEq/L [3.5 mmol/L] 
2. General info  
o Serum deficiency of potassium, the primary intracellular cation, integral for 
cellular function throughout the body  
 
Pathophysiology  
1. Pathology of disease  
o Decreased potassium intake 
o Increased intracellular uptake 
o Gastrointestinal loss 
o Urinary losses 
o Sweat losses 
o Losses via dialysis and plasmapheresis 
2. Incidence, prevalence  
o In a series of PICU admissions in India, 14.8% of patients had hypokalemia 
o No other pediatric incidence / prevalence data found in exhaustive literature 
search 
3. Risk factors  
o Underlying renal or GI condition  
o Diuretic use 
o Malnutrition 
4. Morbidity / mortality  
o Muscle weakness or paralysis, including respiratory failure 
o Ileus 
o Skeletal muscle paresthesias, tetany, muscle tenderness, atrophy 
o Rhabdomyolysis, including myoglobinuric acute renal failure 
o ECG abnormalities, including U waves and cardiac arrhythmias 
o Renal abnormalities, including impaired renal concentrating ability, 
increased renal ammonia production, increased bicarbonate reabsorption, 
and hypokalemic nephropathy 
o Mortality is rare, usually associated with cardiac surgery, arrhythmia, or 
underlying heart disease requiring digoxin therapy  
 
Diagnostics  
1. History  
o HPI  
 Muscle weakness / tenderness / tetany / paresthesias, palpitations, 
polyuria, oliguria, red or brown colored urine, emesis, abdominal 
distention, anorexia 
o Medications  
 Diuretics, asthma medications, insulin, psychotropic medications 
o Family and personal Hx  
 Kidney disease, adrenal disease, mucosal GI disease 
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o Social Hx  
 Huffing, rapid weight loss dieting, access to inciting medications or 
chemicals 
2. Physical exam  
o General  
 May see cachexia, decreased consciousness 
o Musculoskeletal  
 Weakness, tetany, muscular tenderness, atrophy 
o Cardiac  
 Arrhythmias 
o Respiratory  
 Respiratory failure 
o Gastrointestinal  
 Ileus, distention, emesis 
3. Diagnostic testing  
o Laboratory evaluation 
o Serum electrolytes, magnesium, BUN, creatinine 
o Blood gas analysis if suspicion for acid-base disturbance or respiratory 
failure 
o Urinalysis and urine electrolytes if changes in urination or suspicion of 
renal cause or sequelae 
o Drug screen if suspicion for sympathomimetic stimulant intoxication (eg 
amphetamine) 
o Albumin / prealbumin / CRP if concerned about malnutrition 
4. Diagnostic imaging  
o Unnecessary unless otherwise indicated 
5. Other studies  
o Electrocardiogram to assess for cardiac effects of hypokalemia, or if 
arrhythmia noted 
6. Diagnostic "Criteria"  
o Serum potassium < 3.5 mEq/L [3.5 mmol/L] 
 
Differential Diagnosis  
1. Key differential diagnoses  
o Gastroenteritis  
 Classically considered the most common cause of hypokalemia in 
children  
o Malnutrition 
o Renal disease  
o Septicemia  
o Acute diarrhea 
o Heart disease with congestive failure  
o Meningoencephalitis  
o Diuretic use  
o Beta-agonist use 
o Corticosteroid use 
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2. Extensive differential diagnoses  
o Decreased potassium intake  
 Malnutrition 
 Anorexia nervosa 
 Alcoholism 
o Increased intracellular uptake  
 Metabolic alkalosis  
 Respiratory alkalosis  
 Increased circulating insulin  
 Insulin therapy / overdose 
 PO or IV carbohydrate load 
 Elevated beta-adrenergic activity  
 Acute illness 
 Theophylline or beta-agonist therapy 
 Hypokalemic periodic paralysis  
 Familial 
 Thyrotoxic 
 Increased hematopoiesis, including acute leukemia 
 Hypothermia 
 Intoxications  
 Barium 
 Chloroquine 
 Risperidone 
 Quetiapine 
 Cesium 
o Gastrointestinal loss  
 Vomiting 
 Diarrhea (including laxatives, enemas, homeopathic cathartics) 
 Enteral tube drainage 
 Villous adenoma or VIPoma  
o Urinary losses  
 Increased aldosterone effect  
 Primary mineralocorticoid excess, pheochromocytoma, 
Conn's syndrome 
 Increased distal nephron flow  
 Diuretics (acetazolamide, thiazides, loop diuretics) 
 Nonreabsorbable anions  
o Renal Tubular Acidosis type 1 and type 2 
o Diabetic ketoacidosis 
o Toluene abuse (glue-sniffing / huffing) 
o High-dose penicillin therapy 
 Hypomagnesemia  
 Polyuria of any cause 
 Increased potassium secretion  
 Amphotericin B therapy 
 Salt-wasting nephropathies  
 Bartter's or Gitelman's syndrome 
 Tubulointerstitial diseases (eg interstitial nephritis) 
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 Hypercalcemia 
 Acute leukemia (esp monocytic, myelomonocytic)  
o Sweat losses  
 Exercise in hot climate 
 Cystic fibrosis  
o Losses via dialysis and plasmapheresis 
 
Therapeutics  
1. Acute treatment  
o Potassium >3 mEq/L and asymptomatic:  
 Potassium chloride 2 mEq/kg/day PO divided BID to QID (Grade 
2B)  
 More aggressive if heart disease  
 Use potassium bicarbonate or citrate if metabolic acidosis present 
(Grade 2B) 
 May use crystalline form (salt substitute from grocery store), which 
contains 50-65 mEq per teaspoon 
 If unable to take PO, treat as severe symptoms below 
o Potassium 2.5-3 mEq/L or Mild to Moderate Symptoms:  
 Potassium chloride 4 mEq/kg/day PO divided BID to QID until 
serum potassium concentration >3 mEq/L and symptoms resolve 
(Grade 2B) 
 If unable to take PO, treat as severe symptoms 
o Potassium <2.5 mEq/L or Severe Symptoms  
 Potassium chloride IV in saline solution, esp if receiving insulin or 
bicarbonate therapy (Grade 1B)  
 0.5-1 mEq/kg (maximum 30-40 mEq per dose) every 3-4 hrs 
as needed, to infuse at 0.3-0.5 mEq/kg/hr (max 1 mEq/kg/hr)  
o Infusion rate >0.5 mEq/kg/hr may be necessary in 
critical hypokalemia, and warrants continuous ECG 
monitoring  
 Absolute maximal IV rate in an adolescent or 
adult is 20 mEq/hr 
o Maximal IV concentration is 200 mEq/L  
 Concentrations >60 mEq/L are painful and 
should only be infused into a central vein via 
infusion pump 
 Try not to use dextrose solutions, as stimulation of insulin secretion 
will shift potassium into cells from the intravascular space 
 Check serum potassium concentration between IV doses to avoid 
over correction 
o Identify and treat any predisposing conditions 
2. Further management (24 hrs)  
o Match any subsequent replacement to ongoing losses  
 For chronic replacement, consider PO potassium chloride, 
potassium-based salt substitutes sprinkled on food, or potassium-
sparing diuretic (Grade 2B) 
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 Combination of potassium supplement and potassium-sparing 
diuretic requires close monitoring of serum potassium level  
 At least every 4 months in any patient with chronic therapy 
 More frequently if concurrent chronic kidney disease, ACEI 
therapy or ARB therapy, or recent change in potassium or 
diuretic dosing 
o Follow-up ECG if abnormalities were initially present 
o Identify and treat any predisposing conditions 
3. Long-term care  
o Depends upon precipitating cause and predisposing conditions, medications 
 
Follow-Up  
1. Return to office  
o Time frame for return visit  
 Depends upon etiology and stability of potassium level after 
intervention  
 Follow potassium level at least every 4 months in patients on 
potassium supplementation and/or potassium -sparing diuretic 
therapy 
o Recommendations for earlier follow-up:  
 Unstable potassium levels, recent change in medication(s) that affect 
potassium 
2. Refer to specialist  
o After correction of hypokalemia, consultation with specialist may be 
necessary to manage predisposing conditions  
 Consider nephrology if unclear etiology or renal etiology 
 Consider endocrinology if contributing endocrine etiology 
 Consider GI if underlying GI cause 
3. Admit to hospital  
o Recommendations / urgency  
 No evidence regarding criteria for inpatient admission 
o Consider admission if  
 Potassium <2.5 mEq/L, or 
 Pt is symptomatic of hypokalemia 
 
Prognosis  
1. Excellent with control of potassium level and control / resolution of predisposing 
conditions 
2. Complications of treatment include hyperkalemia, cardiac dysrhythmia, and gastric 
erosions or strictures (from PO tablets) 
 
Prevention  
1. Follow potassium level at least every 4 months (more frequently after medicine 
changes and/or changes in patient condition) in patients on potassium -wasting 
diuretic therapy or with conditions that predispose them to hypokalemia  
 
Patient Education 
1. http://www.hmc.psu.edu/healthinfo/h/hypokalemia.htm 
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